The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review

• Asıl Yazarlar: Ludivine Boudieu (Yazar), Myriam Mennetrier (Yazar), Pierre-Michel Llorca (Yazar), Ludovic Samalin (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2023-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Ketamine and its enantiomers represent an innovative glutamatergic agent as a treatment for individuals with treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal ideation and behavior. Intranasal (IN) formulations could allow for quick onset of action on depressive...